Bertram Timothy

DirectorNexImmune, Inc. (NEXI) · full profile →Form 4 · filed Apr 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
0 non-derivative · 8 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 4, 2023Disposed to issuer(D)10K0
Apr 4, 2023Grant(A)10K10K
Apr 4, 2023Disposed to issuer(D)23K0
Apr 4, 2023Grant(A)23K23K
Apr 4, 2023Disposed to issuer(D)13K13K
Apr 4, 2023Grant(A)13K13K
Apr 4, 2023Grant(A)62K62K
Apr 4, 2023Disposed to issuer(D)62K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-023682) within minutes of acceptance. Every field above traces to the original document. Verify it directly: